HARISH v. ARBIT

CourtDistrict Court, D. New Jersey
DecidedJanuary 31, 2025
Docket2:21-cv-11088
StatusUnknown

This text of HARISH v. ARBIT (HARISH v. ARBIT) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HARISH v. ARBIT, (D.N.J. 2025).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY : ZIV HARISH, : Civil Action No. 21-11088-EP-AME : Plaintiff, : v. : OPINION and ORDER : EHUD ARBIT, et al., : : Defendants. : : ESPINOSA, U.S.M.J. This matter is before the Court on the motion by Plaintiff Ziv Harish (“Plaintiff”) to disqualify counsel for Defendants Dr. Ehud Arbit (“Arbit”) and Isaac Rubinstein (“Rubinstein”) (together, “Defendants”): Marc Cooperman, Brian Apel, Jake Earl, Erik Maurer, Katherine Escanlar, as well as the law firms of Banner & Witcoff, Ltd. and Saiber, LLC (collectively, “Defense Counsel”).1 [D.E. 92]. Defendants oppose the motion. [D.E. 102]. The Court has reviewed and considered the papers submitted in connection with the motion by the respective parties and heard oral argument on the motion. [See D.E. 138 and 164]. For the following reasons, and for good cause shown, Plaintiff’s motion to disqualify is GRANTED.

1 Plaintiff seeks the disqualification of all counsel for Defendants. [See D.E. 92-1 at 5]. Throughout this Opinion and Order, the term “Defense Counsel” will refer to all counsel for Defendants or any single defense lawyer, unless more specificity is required by the circumstances. I. RELEVANT BACKGROUND A. Factual Background2 Plaintiff alleges he was the sole inventor of the subject matter claimed in U.S. Patent No. RE46,823 (the “‘823 Patent”). [D.E. 19 at 18, ¶ 113]. In this declaratory judgment action, Plaintiff seeks to quiet title to the ‘823 Patent and to be determined the sole inventor of the subject of the ‘823 Patent, which currently names Plaintiff and Defendants as inventors. 3 [See id.

at 18; D.E. 19-1 at 2]. Defendants assert counterclaims against Plaintiff and pro se Defendant Russel Weinzimmer (“Weinzimmer”) for fraud, conversion, trespass to chattels, and civil conspiracy. [See D.E. 41 at 45-51]. Defendants also assert crossclaims against Weinzimmer for malpractice, negligence, and breach of his fiduciary duty in connection with his work as the patent attorney who prosecuted the ‘823 Patent. [See id. at 51-58]. In June 2020, Defendants executed a Patent Assignment and Purchase Agreement (the “Assignment Agreement”), wherein Defendants sold and assigned their rights in the ‘823 Patent to a third party, Lincoln Diagnostics, Inc. (“Lincoln”). [See D.E. 92-2]. The Assignment Agreement contains a “Representations and Warranties” section, which recites the ways in which

each Defendant contributed to the invention in the ‘823 Patent. [Id. at 4]. For example, this section provides that “Arbit conceived of the use of the pain gate theory in conjunction with allergy skin test devices and conceived of the physical proximity between the numbing dull pressure head and the sharp element required for the allergy skin test device.” [Id.]. It also provides that “Rubinstein conceived of the actual design of the claimed allergy skin test device

2 This factual summary, drawn from the parties’ motion papers, provides context and background for this Opinion. While the Opinion is based on the record presented by the parties, nothing herein shall constitute a conclusive finding of fact or a definitive assessment of the weight of the evidence. 3 The ‘823 Patent is a broadening reissue of U.S. Patent No. 8,597,199 (the “‘199 Patent”), which also names Plaintiff and Defendants as inventors. [See D.E. 19 at 8]. to ensure the proper timing and distance between the numbing dull pressure heads and the sharp elements for introducing allergens to the skin.” [Id.]. Defendants represented and warranted to Lincoln in this section that they “own[] all rights and title to an undivided interest to the entirety of the Patent Rights,” and that “[t]here are no existing contracts, agreements, options, commitments, or rights with, to, or in any person or entity to acquire or license any of the Patent

Rights.” [Id.]. The Assignment Agreement also contains a section titled “Cooperation.” [D.E. 92-2 at 5]. In this section, Defendants agreed to execute all such papers as may be necessary to perfect Lincoln’s title to the Patent Rights, to communicate all known facts respecting the inventions, improvements, and discoveries therein, to testify as parties in any legal or administrative proceedings in person and by declaration, to be named as parties and be represented by Lincoln in any such proceedings, to sign all lawful papers, to assist Lincoln in establishing their inventive contributions, and generally to do all things necessary to aid Lincoln to obtain and enforce for its own benefit, ownership of and patent protection for, the inventions, improvements, and discoveries of the Patent Filings, all at the expense of Lincoln.

[Id.] (emphasis supplied). Additionally, the Assignment Agreement contains an “Indemnification” section, which provides that “Lincoln agrees to indemnify Assignors against disputes concerning the ownership of the Patent Rights filed by either Ziv Harish or Russ Weinzimmer.” [D.E. 92-2 at 5]. The indemnity lasts until the expiration of the patent rights, and this section specifies that “[t]he liability under this indemnity shall in no case exceed $250,000.” [Id.]. Under a section titled “Payment and Refund,” the Assignment Agreement further provides that “[t]he entire Patent Purchase Payment paid by Lincoln to [Defendants] shall be immediately and fully refunded by [Defendants] if any of the [Defendants’] undertakings, obligations, representations, and warranties under this Agreement are breached.” [Id. at 3]. It appears Plaintiff became aware of the Assignment Agreement in December 2020, see D.E. 102-5, and filed this action on May 11, 2021. [D.E. 1]. Not long thereafter, on May 25, 2021, Defendants and Lincoln entered into a Common Interest and Litigation Cooperation

Agreement and a Consent to and Waiver of Conflicts of Interest Agreement with the law firm, Banner & Witcoff, Ltd. (“Banner Witcoff”), so that Banner Witcoff could represent Defendants in this lawsuit. [D.E. 102 at 8; D.E. 102-16, Declaration of Dr. Ehud Arbit (“Arbit Dec.”) ¶¶3-4; D.E. 102-15, Declaration of Isaac Rubinstein (“Rubenstein Dec.”) ¶¶3-4]. An attorney at the law firm Saiber LLC (“Saiber”) entered her appearance as counsel for Defendants in August 2021, see D.E. 5, and in September 2021, the Court granted Defendants’ application to admit pro hac vice Marc S. Cooperman, Erik Maurer, and Brian Apel at Banner Witcoff as attorneys for Defendants. [D.E. 9]. Plaintiff did not object to the pro hac vice admission of those Banner Witcoff attorneys. [D.E. 7]. On September 24, 2021, Defendants and

Lincoln executed a Consent to and Waiver of Conflicts of Interest with Saiber. [See D.E. 102 at 8-9; D.E. 102-16, Arbit Dec. ¶5; D.E. 102-15, Rubenstein Dec. ¶5]. On October 4, 2021, Plaintiff filed a third-party litigation funding disclosure statement pursuant to Local Civil Rule 7.1.1., which stated that no person or entity was providing him with funding for this action. [D.E. 16]. Neither Defendants nor Weinzimmer filed such disclosures. On November 14, 2022, Plaintiff, through counsel, delivered to Defendants, through counsel, proposed settlement terms, under which Defendants would agree that Plaintiff is the sole inventor of the reissued ‘823 Patent and would acknowledge that Defendants’ sale and assignment of rights in the ‘823 Patent to Lincoln was invalid “since they had no rights to convey.” [See D.E. 92-4]. On January 30, 2023, Defendants delivered a counteroffer, which, among other terms, stated that Defendants would agree that Plaintiff is the sole inventor of the Patent, but the assignment to Lincoln would stay in place. [D.E. 92-5]. That counteroffer also proposed that Plaintiff would grant Lincoln a covenant not to sue under the reissued ‘823 Patent, the ‘199 Patent, or any related patents; would agree not to practice the reissued ‘823 Patent, the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Miller, William G.
624 F.2d 1198 (Third Circuit, 1980)
In Re Dolan
384 A.2d 1076 (Supreme Court of New Jersey, 1978)
City of Atlantic City v. Trupos
992 A.2d 762 (Supreme Court of New Jersey, 2010)
Gould, Inc. v. Mitsui Mining & Smelting Co.
738 F. Supp. 1121 (N.D. Ohio, 1990)
Alexander v. Primerica Holdings, Inc.
822 F. Supp. 1099 (D. New Jersey, 1993)
In Re Kamp
194 A.2d 236 (Supreme Court of New Jersey, 1963)
In Re the State Grand Jury Investigation
983 A.2d 1097 (Supreme Court of New Jersey, 2009)
Wyeth v. Abbott Laboratories
692 F. Supp. 2d 453 (D. New Jersey, 2010)
Essex County Jail Annex Inmates v. Treffinger
18 F. Supp. 2d 418 (D. New Jersey, 1998)
In re: Jeffrey J. Prosser v.
777 F.3d 154 (Third Circuit, 2015)
In Re Marvel Entertainment Group, Inc.
140 F.3d 463 (Third Circuit, 1998)
Boy Scouts of America v.
35 F.4th 149 (Third Circuit, 2022)
Carreno v. City of Newark
834 F. Supp. 2d 217 (D. New Jersey, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
HARISH v. ARBIT, Counsel Stack Legal Research, https://law.counselstack.com/opinion/harish-v-arbit-njd-2025.